Rankings
▼
Calendar
MCK Q2 2025 Earnings — McKesson Corporation Revenue & Financial Results | Market Cap Arena
MCK
McKesson Corporation
$115B
Q2 2025 Earnings
Healthcare
Medical - Distribution
Income Statement
Revenue
$93.7B
+21.3% YoY
Gross Profit
$3.1B
3.4% margin
Operating Income
$745M
0.8% margin
Net Income
$241M
0.3% margin
EPS (Diluted)
$1.86
QoQ Revenue Growth
+18.1%
Cash Flow
Operating Cash Flow
$2.1B
Free Cash Flow
$1.9B
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$72.4B
Total Liabilities
$75.1B
Stockholders' Equity
-$3.0B
Cash & Equivalents
$2.5B
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$93.7B
$77.2B
+21.3%
Gross Profit
$3.1B
$2.9B
+8.6%
Operating Income
$745M
$898M
-17.0%
Net Income
$241M
$664M
-63.7%
Revenue Segments
U.S. Pharmaceutical Segment
$85.7B
92%
International Segment
$3.7B
4%
Medical-Surgical Solutions Segment
$2.9B
3%
Prescription Technology Solutions
$1.3B
1%
← FY 2025
All Quarters
Q3 2025 →